Prolynx is a biotechnology company dedicated to developing ultra-long-acting medicines for obesity and other metabolic diseases. We are advancing a proprietary portfolio of extended-duration therapeutic candidates targeting once-monthly and once-quarterly dosing, with the potential to smooth the PK peaks and troughs that can contribute to tolerability issues and to support more consistent, long-term treatment.
| Website | http://www.prolynxinc.com |
| Employees | 35 (18 on RocketReach) |
| Founded | 2009 |
| Address | 135 Mississippi St, San Francisco, California 94107, US |
| Phone | +1 415-665-3377 |
| Technologies |
HTML
,
G Suite
,
Bootstrap
+5 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Drug Delivery |
| Competitors | ServiceTitan, Housecall Pro, Acumatica, Brightpearl by Sage, FieldPulse, Tradify, FieldAware, mHelpDesk, ServiceM8, Stahlman-England +46 more (view full list) |
Looking for a particular Prolynx employee's phone or email?
Chris Boulton is the CEO of Prolynx.
18 people are employed at Prolynx.
Prolynx is based in San Francisco, California.